EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CaMKII Exacerbates Doxorubicin‐Induced Cardiotoxicity by Promoting Ubiquitination Through USP10 Inhibition

Yitong Yang iD, Zhenyi Wang, Nisha Wang, Jian Yang, Lifang Yang

Cancer Medicine · 2024

DOI: 10.1002/cam4.70286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Yitong Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Children's Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Doxorubicin, Calcium-Calmodulin-Dependent Protein Kinase Type 2, Cardiotoxicity, Ubiquitination. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Outstanding Youth Foundation of Shaanxi Province, Science and Technology Program of Xi'an.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Doxorubicin (DOX) is an effective anticancer drug, but it has a problem of cardiotoxicity that cannot be ignored. Ca 2+ /calmodulin‐dependent protein kinase II (CaMKII) is tightly associated with the pathological progression of DOX‐induced cardiotoxicity. Ubiquitin‐specific protease 10 (USP10) plays an important role in many biological processes and cancers. However, its association with DOX‐induced cardiotoxicity and CaMKII remains unclear.

Methods

H9C2 cells, HL‐1 cells and C57BL/6 mice were used to establish the DOX‐induced cardiotoxicity model, and the CaMKII‐specific inhibitor KN‐93 and USP10 specific inhibitor Spautin‐1 were used to observe the CaMKII and USP10 effect. In cell experiments, CCK‐8 method was used to assess cell viability, LDH kit was used to assess lactate dehydrogenase expression, DCFH‐DA staining was used to observe changes in active oxygen content, TUNEL staining was used to observe cell apoptosis, and Western blotting method was used to detect relevant protein markers. The expression of p‐CaMKII and USP10 was assessed by immunofluorescence staining. In animal experiments, mouse echocardiograph was used were used to evaluate cardiac function, and HE staining and Masson staining were used to evaluate myocardial injury. Cardiomyocyte apoptosis was detected by TUNEL staining. Western blotting method was used to detect relevant protein markers.

Results

Our results demonstrated that activation of CaMKII and inhibition of USP10 pathway related to DOX‐induced cardiotoxicity. Inhibition of CaMKII with KN‐93 ameliorated DOX‐induced cardiac dysfunction and cytotoxicity. In addition, CaMKII inhibition prevented DOX‐induced apoptosis and ubiquitination. Furthermore, CaMKII inhibition increased USP10 expression in DOX‐treated mouse hearts, H9C2 cells and HL‐1 cells. At last, the USP10 inhibitor, Spautin‐1, blocked the regulatory effect of CaMKII inhibition on apoptosis and ubiquitination in DOX‐induced cardiotoxicity.

Conclusion

Our findings revealed that DOX‐induced myocardial apoptosis and activated CaMKII through cellular and animal levels, while providing a novel probe into the mechanism of CaMKII action: promoting ubiquitination by inhibiting USP10 aggravated apoptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinCalcium-Calmodulin-Dependent Protein Kinase Type 2CardiotoxicityUbiquitinationApoptosisUbiquitin ThiolesteraseMyocytes, CardiacAnimalsMiceMice, Inbred C57BLBenzylaminesMaleSulfonamidesCell LineDisease Models, AnimalBenzenesulfonamidesQuinazolines

Stichwörter der Autor:innen

CaMKIIH9C2USP10 pathwaycardiotoxicitydoxorubicinubiquitination

Substanzen

DoxorubicinCalcium-Calmodulin-Dependent Protein Kinase Type 2KN 93Ubiquitin ThiolesteraseBenzylaminesUSP10 protein, mouseSulfonamidesspautin-1BenzenesulfonamidesQuinazolines

Autor:innen und Institutionen

  • Department of Anesthesiology, Children's Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Department of Children's Respiratory Asthma, Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.
  • Department of Cardiovascular Surgery, Xijing Hospital, Air Force Medical University, Xi'an, China.

ORCID-Profile: Yitong Yang

Förderung

  • National Natural Science Foundation of China
  • Outstanding Youth Foundation of Shaanxi Province
  • Science and Technology Program of Xi'an

Zitieren

APA

Yang, Y., Wang, Z., Wang, N., Yang, J., & Yang, L. (2024). CaMKII Exacerbates Doxorubicin‐Induced Cardiotoxicity by Promoting Ubiquitination Through USP10 Inhibition. Cancer Medicine. https://doi.org/10.1002/cam4.70286

Vancouver

Yang Y, Wang Z, Wang N, Yang J, Yang L. CaMKII Exacerbates Doxorubicin‐Induced Cardiotoxicity by Promoting Ubiquitination Through USP10 Inhibition. Cancer Medicine. 2024. doi:10.1002/cam4.70286

BibTeX
@article{Yang2024,
  author = {Yang, Yitong and Wang, Zhenyi and Wang, Nisha and Yang, Jian and Yang, Lifang},
  title = {CaMKII Exacerbates Doxorubicin‐Induced Cardiotoxicity by Promoting Ubiquitination Through USP10 Inhibition},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70286}
}
Kostenlos starten →